Drug Profile
Research programme: CC-chemokine receptor 4 antagonists - Astellas Pharma
Alternative Names: AS 1611113; AS 191710; AS 191711; CCR4 receptor antagonists - Astellas PharmaLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Astellas Pharma
- Class
- Mechanism of Action CCR4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Dermatitis; Rheumatoid arthritis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in Japan
- 16 Jul 2016 No recent reports of development identified for preclinical development in Dermatitis in Japan
- 16 Jul 2016 No recent reports of development identified for preclinical development in Rheumatoid-arthritis in Japan